Praktické lékárenství, 2010, issue 6

Editorial

Slovo úvodem

PharmDr. Alena Petříková

Prakt. lékáren. 2010; 6(6): 267  

Current pharmacotherapy

Treatment of chronic wounds with modern dressing materials

prof.MUDr.Alena Pospíšilová, CSc.

Prakt. lékáren. 2010; 6(6): 276-281  

The recent decades have seen major changes in the local treatment of chronic wounds. New dressing materials have become available which enable moist wound healing conditions. The concept of moist wound care has started an era of development and manufacture of dozens to hundreds other products of various kinds and different effects, aimed at providing a moist wound environment. Modern dressing materials offered by the pharmaceutical industry today have been developed based on the recent knowledge of wound healing. These modern materials used primarily in the treatment of chronic wounds vary in their consistency, material composition and, as...

Chronic daily headache and it's treatment

MUDr.Ingrid Niedermayerová

Prakt. lékáren. 2010; 6(6): 282-284  

Chronic daily headache (CDH) represents a heterogenous group including both primary and secondary headaches resulting from various organic causes. Primary CDH results from chronification of migraine, tension headache or cluster headache. It is often associated with overuse of analgetics or other acute medications, or with depression and anxiety. Treatment depends on the underlying type of headache and present complications. Serious conditions require hospitalization.

Local administration of drugs in children with upper airway disease in otorhinolaryngology

prof.MUDr.Jaromír Astl, CSc.

Prakt. lékáren. 2010; 6(6): 286-290  

The present overview of upper airway inflammations deals with the development and symptoms of the diseases in the practice and their possible treatment. The treatment of complications is beyond the scope of this paper. The most commonly used groups of locally administered medications are described which are used for the treatment of patients with an emphasis on symptomatic treatment, particularly the options of administering local medications in the form of sprays and drops.

Trends in hormonal contraception

MUDr.Michael Fanta, Ph.D.

Prakt. lékáren. 2010; 6(6): 291-293  

Currently, a wide range of methods and formulations of hormonal contraception are commercially available which are similarly reliable, safe and tolerated. Thus, there are efforts to develop formulations with additional beneficial properties. The reduction in the dose of the oestrogen component has stopped at 15 μg of ethinylestradiol, a predominant oestrogen component until recently. Not long ago, an alternative in the form of natural estradiol, or estradiol valerate, was introduced in a combined oral contraceptive (COC). Poor cycle control, the limiting factor thus far, has been overcome by the combination with new gestagens. In the gestagen...

Medicamenta nova

Victoza (liraglutid)

MUDr.Jitka Jurková

Prakt. lékáren. 2010; 6(6): 271-274  

The article informs about Victoza (liraglutid) which is a glucagon-like-peptid-1 analogue (GLP1). It is used to treat patients with diabetes mellitus type 2 with insufficient compensation of diabetes during metformin and/or derivates of sulfonylurey or metformin and thiazolidindion therapy. Liraglutid stimulates the insulin secretion depending upon the concentration of glucose in blood and reduces an incorrectly high secretion of glucagon. Liraglutid also reduces body weight and the amount of body fat thanks to the suppression of the feeling of hunger and reduction of energy intake. The treatment with Victoza leads to a significant improvement...

Pharmaceutical technology

New medicinal substances in extemporaneous prescription, part 4 - xylometazoline hydrochloride

PharmDr.Zbyněk Sklenář, Ph.D.

Prakt. lékáren. 2010; 6(6): 296-299  

Xylometazoline hydrochloride is a popular and widely used active decongestant ingredient in a number of over-the-counter nasal products. Most recently, this agent has been available since July 2010 as a pharmaceutical substance for the preparation of medicines, which provides us with a directly-acting alpha-sympathomimetic agent stable in an aqueous environment. The review article provides information on the properties and use of the substance applied in products for nasal and/or ophthalmic administration. Also presented are examples of combined products particularly intended for nasal administration which can add to the current supply of proprietary...

New medicinal substances in extemporaneous prescription, part 5 - promethazine hydrochloride

PharmDr.Zbyněk Sklenář, Ph.D., Mgr.Kateřina Horáčková

Prakt. lékáren. 2010; 6(6): 300-302  

Promethazine hydrochloride is a well-known and long-established antihistamine with a variety of other pharmacological effects for which it is currently used more than for its basic indication of an H1 antihistamine. Since it is, when appropriate, still used mainly in paediatric patients and since the only dosage form of monocomponent products available in the market is that of a film-coated tablet, which does not allow for proper splitting when a lower dose is prescribed, it is desirable that the medicinal substance itself be available for extemporaneous use. It has been available for pharmacies since September 2010. The review article provides...

For pharmaceutical assistants

Effective day and night treatment of cold sore

MUDr.Iva Obstová

Prakt. lékáren. 2010; 6(6): 303-304  

Recurrent herpes simplex infection is not among the most serious infections; however, it is particularly troublesome in terms of social and aesthetic aspects. Since the herpes virus cannot be eliminated from an already infected organism, the treatment of recurrent herpes simplex infection has to focus on facilitating the symptoms and alleviation of associated symptoms. Compresses, pastes, antiseptic agents, antiviral drugs, biostimulation lasers and other methods may be used in the treatment. The COMPEED® hydrocolloid patch is a new product for the healing of small wounds.

Nonprescription drugs and self-medication of diarrhoea and constipation

Mgr.Martin Doseděl, Mgr.Josef Malý, PharmDr.MUDr.Kamil Rudolf

Prakt. lékáren. 2010; 6(6): 306-311  

At a time when the WHO puts an emphasis on every individual’s responsibility for their health, self-medication can be considered a positive part of an individual’s health behaviour. Diarrhoea and constipation are common symptoms for which the patients visit a pharmacy during self-medication. The pharmacist and pharmaceutical assistant should be the ones to guarantee safe and effective self-medication.

Summary of dietary supplements in sports nutrition

Mgr.Pavel Koktavý

Prakt. lékáren. 2010; 6(6): 312-316  

Sports activity impose excesive requirements on human body. Body can loose energy, vitamins and also minerals. That is the reason why well-balanced diet is important at any of sports activity. Not only for stimulation and achievement but also for regeneration and protection body against harm. Sports nutrition presents well-digestible and useful energy in comparison with common nourishment.

Pharmacist and the Internet

Norské lékárny testují elektronický recept

PharmDr.Martin Dočkal

Prakt. lékáren. 2010; 6(6): 317  

Comment

Victoza (liraglutid). Komentář ke článku (Prakt. lékáren. 2010; 6(6): 271-274)

doc. PharmDr. Martin Doležal, Ph.D.

Prakt. lékáren. 2010; 6(6): 275  

Quiz

Autodidaktický test 6/2010

Prakt. lékáren. 2010; 6(6): 318  


Pharmacy for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.